Walleye Capital
ASND icon

Walleye Capital’s Ascendis Pharma A/S ASND Stock Holding History

Walleye Capital’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.85M Buy
8,100
+7,300
+913% +$1.85M ﹤0.01% 2904
2026
Q2 		$213K Sell
800
-1,800
-69% -$420K ﹤0.01% 3457
2026
Q1 		$595K Sell
2,600
-200
-7% -$44.8K ﹤0.01% 2518
2025
Q4 		$597K Buy
2,800
+2,500
+833% +$516K ﹤0.01% 2844
2025
Q3 		$59.6K Buy
300
+200
+200% +$37.3K ﹤0.01% 3940
2025
Q2 		$17.3K Sell
100
-500
-83% -$81.4K ﹤0.01% 4255
2025
Q1 		$93.5K Buy
+600
New +$85.7K ﹤0.01% 3654
2024
Q3 		– Sell
-1,700
Closed -$232K – 5259
2024
Q2 		$232K Sell
1,700
-100
-6% -$13.6K ﹤0.01% 4190
2024
Q1 		$272K Sell
1,800
-700
-28% -$100K ﹤0.01% 3743
2023
Q4 		$315K Sell
2,500
-600
-19% -$59.8K ﹤0.01% 3339
2023
Q3 		$290K Buy
+3,100
New +$290K ﹤0.01% 3264
2023
Q2 		– Sell
-4,400
Closed -$472K – 4293
2023
Q1 		$472K Sell
4,400
-1,100
-20% -$126K 0.01% 1762
2022
Q4 		$672K Buy
5,500
+4,200
+323% +$488K 0.01% 1250
2022
Q3 		$134K Buy
+1,300
New +$123K ﹤0.01% 2298

Other funds holding ASND

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Walleye Capital's ASND Position: Q3 2026 in Review

Walleye Capital reduced its Ascendis Pharma A/S (ASND) stake by 98% in Q3 2026, selling an estimated $31.4M and leaving 2,171 shares worth $495K. The position accounts for ﹤0.01% of the portfolio, ranked #4114.

Walleye Capital first reported a position in ASND in Q4 2023 and has held it in 10 quarters since. The position peaked at $33.6M in Q2 2026. 252 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Walleye Capital held 2,171 shares of Ascendis Pharma A/S worth $495K as of Q3 2026.
  • Walleye Capital sold 123,834 Ascendis Pharma A/S shares in Q3 2026, an estimated $31.4M.
  • Ascendis Pharma A/S made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #4114 holding.
  • Walleye Capital first reported a position in Ascendis Pharma A/S in Q4 2023 and has held it in 10 quarters since.
  • Walleye Capital's Ascendis Pharma A/S position peaked at $33.6M in Q2 2026.
  • 252 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.